Efficiency of venlafaxine in patients with psychogenic nonepileptic seizures and anxiety and/or depressive disorders.
An open-label, experimental, prospective 5-month follow-up study was performed with 19 patients with psychogenic nonepileptic seizures and anxiety disorder and/or depression who were treated with venlafaxine. The authors held monthly visits and evaluated changes in baseline Hamilton Depression Rating Scale scores, Hamilton Anxiety Rating Scale scores, and the number of psychogenic nonepileptic seizures. HAM-D scores, HAM-A scores, and the number of nonepileptic seizures showed a statistically significant decrease which was maintained over the study period. Based on this study, the authors conclude that venlafaxine may help reduce nonepileptic seizures in patients with additional anxious and/or depressive symptoms.